16
Jul
2010
Action Pharma, A/S: Series C $6.3M
Posted in I - Series C, Q - 2Q10, R - INTERNATIONAL, X - Inflammation, X - Renal
Action Pharma (Denmark) a clinical-stage biopharmaceutical company focused on acute kidney injury in patients undergoing cardiac surgery and inflammation, closed a $6.3M Series C financing. Participants include Sunstone Capital, Global Life Science Ventures, SLS Invest and InnovationsKapital.
OnBioVC PARTNERS
-
